Episode #46 - Pioneering Cannabis Bioharmaceuticals with Cannovation Clinical Research Partners, LLC. Lisa Rich Milan and Michael Zaccaria
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Episode #46 - Pioneering Cannabis Bioharmaceuticals with Cannovation Clinical Research Partners, LLC. Lisa Rich Milan and Michael Zaccaria
-
Narrado por:
-
De:
Acerca de esta escucha
In this insightful episode of Roots to Risk, hosts Eric Schneider and Isaac Bock welcome back Lisa Rich Milan, alongside her co-founder Michael Zaccaria, to delve into their groundbreaking new venture, Cannovation Clinical Research Partners, LLC.
Shifting from the traditional CPG discussions, this episode explores the innovative biotech and pharmaceutical approaches to cannabis. Lisa and Michael share their vision of expediting drug discovery and bringing cannabis-related medical products to market, shedding light on regulatory challenges, the impact of rescheduling cannabis to a Schedule III substance, and the promising future of cannabis in the pharmaceutical landscape.
Tune in to learn about the intersection of cannabis, biotech, and the potential for significant advancements in medical treatments.